raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:35704

L-Arginine:glycine amidinotransferase deficiency

Synonyms: AGAT deficiency

Type
Disease
Group
Disorder
Inheritance
Autosomal recessive
Age of onset
Infancy
Status
active

L-Arginine:glycine amidinotransferase (AGAT) deficiency is a very rare type of creatine deficiency sydrome characterized by global developmental delay, intellectual disability, and myopathy.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enL-Arginine:glycine amidinotransferase deficiencyAGAT deficiency
frDéficit en l-arginine:glycine amidinotransféraseDéficit en AGAT
deL-Arginin:Glycin-Amidinotransferase-MangelAGAT-Mangel
esDeficiencia de L-arginina:glicina amidinotransferasaDeficiencia AGAT
itDeficit di l-Arginina:glicina amidinotransferasiDeficit di AGAT
nlL-Arginine:glycine-amidinotransferasedeficiëntieAGAT-deficiëntie
ptDeficiência de arginina:glicina amidinotransferase
plNiedobór amidynotransferazy L-arginina:glicynaNiedobór AGAT
csDeficit L-arginin:glycin amidinotransferázyDeficit AGAT
ukДефіцит L-аргініну:гліцин-амідинотрансферазиДефіцит AGAT
zh精氨酸-甘氨酸脒基转移酶缺乏AGAT缺乏症
trL-Arjinin: glisin amidinotransferaz eksikliğiAGAT eksikliği

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM612718Evalidated
ICD-10E72.8NTBTattributedvalidated
ICD-115C53.4NTBTindexvalidated
MONDO0012996Evalidated
MeSHC567192Evalidated
UMLSC2675179Evalidated
GARD10323Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (2):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
GATMDisease-causing germline mutation(s) inAssessedHGNC:4175ENSG0000017176660236015q21.1glycine amidinotransferase20301745[PMID]
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Cases/families9 casesWorldwideCase(s)Validated20301745[PMID]_20625172[PMID]
Point prevalence<1 / 1 000 000—WorldwideClass onlyValidatedORPHANET

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

17 annotations · validated 2025-07-17
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0100543Cognitive impairment
HP:0001263Global developmental delay
HP:6000572Reduced tissue arginine:glycine amidinotransferase activity
Frequent (79-30%)
HP:0034597Decreased CSF creatinine concentration
HP:0012101Decreased serum creatinine
HP:6000748Decreased urinary creatine level
HP:6000115Decreased urine creatinine level
HP:0034888Decreased urine guanidinoacetic acid level
HP:0000750Delayed speech and language development
HP:0001324Muscle weakness
HP:0003198Myopathy
HP:0025051Reduced brain creatine level by MRS
HP:0034292Reduced circulating creatine concentration
Occasional (29-5%)
HP:0000708Atypical behavior
HP:0001288Gait disturbance
HP:0001252Hypotonia
HP:0001250Seizure

Run the differential on the 3 obligate / very frequent terms

Annotation source: 26490222[PMID]_28971744[PMID]_26542286[PMID]

7

Sources for this card